<?xml version="1.0" ?>
<document id="8d3f0c18b7b274179244f57cd8f66e185a009dd5">
  <chunk id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c0" text="Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection">
    <entity charOffset="0-9" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c0.e0" ontology_id="CHEBI_22587" text="Antiviral" type="chemical"/>
  </chunk>
  <chunk id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1" text="Interleukin-11 (IL-11), a well-known anti-inflammatory factor, provides protection from intestinal epithelium damage caused by physical or chemical factors. However, little is known of the role of IL-11 during viral infections. In this study, IL-11 expression at mRNA and protein levels were found to be high in Vero cells and the jejunum of piglets during porcine epidemic diarrhea virus (PEDV) infection, while IL-11 expression was found to be positively correlated with the level of viral infection. Pretreatment with recombinant porcine IL-11 (pIL-11) was found to suppress PEDV replication in Vero E6 cells, while IL-11 knockdown promoted viral infection. Furthermore, pIL-11 was found to inhibit viral infection by preventing PEDV-mediated apoptosis of cells by activating the IL-11/STAT3 signaling pathway. Conversely, application of a STAT3 phosphorylation inhibitor significantly antagonized the anti-apoptosis function of pIL-11 and counteracted its inhibition of PEDV. Our data suggest that IL-11 is a newfound PEDV-inducible cytokine, and its production enhances the anti-apoptosis ability of epithelial cells against PEDV infection. The potential of IL-11 to be used as a novel therapeutic against devastating viral diarrhea in piglets deserves more attention and study.">
    <entity charOffset="189-193" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="263-267" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e1" ontology_id="CHEBI_33699" text="mRNA" type="chemical"/>
    <entity charOffset="272-279" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e2" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="865-874" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e3" ontology_id="CHEBI_35222" text="inhibitor" type="chemical"/>
    <pair e1="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e0" e2="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e1" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.p0" relation="true"/>
    <pair e1="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e0" e2="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e2" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.p1" relation="true"/>
    <pair e1="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e0" e2="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e3" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.p2" relation="true"/>
    <pair e1="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e1" e2="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e2" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.p3" relation="true"/>
    <pair e1="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e1" e2="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e3" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.p4" relation="true"/>
    <pair e1="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e2" e2="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.e3" id="8d3f0c18b7b274179244f57cd8f66e185a009dd5.c1.p5" relation="true"/>
  </chunk>
</document>
